The lack of uniformity of criteria for defining recipient-site infection after oral oncologic surgery with simultaneous reconstruction is problematic despite numerous studies on this issue. This study aimed to investigate the difference in the criteria for defining recipient-site infection after oral oncologic surgery with reconstruction.
Methods:
A Medline search was performed via PUBMED using the following combinations of key terms that were tagged in the title, abstract, or both: “surgical site infection—head neck,” “surgical site infection—oral cancer,” “antibiotic prophylaxis—head neck,” and “surgical site infection—oral carcinoma.” Search results were filtered between 2005 and 2017. Articles in which there was no mention of the criteria for definition of surgical-site infection were excluded.
Results:
The number of articles that met the inclusion criteria was 24. The lack of uniformity in the criteria for defining recipient-site infection in each article appeared to be attributable mainly to differences in whether an orocutaneous fistula and superficial incisional infection were regarded as recipient-site infection.
Conclusion:
Reconsideration of the categorization of orocutaneous fistula as infection, regardless of the etiology, and differentiation of superficial and deep incisional infections are necessary for correct assessment of recipient-site infection in oral oncologic surgery.
Get full access to this article
View all access options for this article.
References
1.
MazurekMJ, RyszM, JaworowskiJ, et al.Contamination of the surgical field in head and neck oncologic surgery. Head Neck, 2014; 36:1408–1412.
2.
CunhaTF, Soares MelanciaTA, Zagalo Fernandes RibeiroCM, et al.Risk factors for surgical site infection in cervico-facial oncological surgery. J Craniomaxillofac Surg, 2012; 40:443–448.
3.
YarlagaddaBB, DeschlerDG, RichDL, et al.Head and neck free flap surgical site infections in the era of the Surgical Care Improvement Project. Head Neck, 2016; 38:E392–E398.
4.
HoranTC, GaynesRP, MartoneWJ, et al.CDC definitions of nosocomial surgical site infections, 1992: A modification of CDC definitions of surgical wound infections. Am J Infect Control, 1992; 20: 271–274.
5.
MangramAJ, HoranTC, PearsonML, et al.Guideline for Prevention of Surgical Site Infection, 1999. Centers for Disease Control and Prevention (CDC) Hospital Infection Control Practices Advisory Committee. Am J Infect Control, 1999; 27:97–132.
6.
JohnsonJT, MyersEN, ThearlePB, et al.Antimicrobial prophylaxis for contaminated head and neck surgery. Laryngoscope, 1984; 94:46–51.
7.
HirakawaH, HasegawaY, HanaiN, et al.Surgical site infection in clean–contaminated head and neck cancer surgery: Risk factors and prognosis. Eur Arch Otorhinolaryngol, 2013; 270:1115–1123.
8.
MiletPR, MalletY, El BedouiS, et al.Head and neck cancer surgery in the elderly: Does age influence the postoperative course?. Oral Oncol, 2010; 46:92–95.
9.
PenelN, FournierC, LefebvreD, et al.Multivariate analysis of risk factors for wound infection in head and neck squamous cell carcinoma surgery with opening of mucosa: Study of 260 surgical procedures. Oral Oncol, 2005; 41:294–303.
10.
SatoJ, GotoJ, HarahashiA, et al.Oral health care reduces the risk of postoperative surgical site infection in inpatients with oral squamous cell carcinoma. Support Care Cancer, 2011; 19:409–416.
11.
WangCH, WongYK, WangCP, et al.Risk factors of recipient site infection in head and neck cancer patients undergoing pectoralis major myocutaneous flap reconstruction. Eur Arch Otorhinolaryngol, 2015; 272:3475–3482.
12.
LinWJ, WangCP, WangCC, et al.The association between surgical site infection and previous operation in oral cavity cancer patients. Eur Arch Otorhinolaryngol, 2012; 269:989–997.
13.
LiuSA, WongYK, WangCP, et al.Surgical site infection after preoperative neoadjuvant chemotherapy in patients with locally advanced oral squamous cell carcinoma. Head Neck, 2011; 33:954–958.
14.
LiuSA, WongYK, PoonCK, et al.Risk factors for wound infection after surgery in primary oral cavity cancer patients. Laryngoscope, 2007; 117:166–171.
15.
AkashiM, FurudoiS, HashikawaK, et al.Postoperative abnormal response of C-reactive protein as an indicator for infectious complications after oral oncologic surgery with primary reconstruction. J Otolaryngol Head Neck Surg, 2015; 44:13.
16.
Candau-AlvarezA, Linares-SiciliaMJ, Dean-FerrerA, et al.Role of culture of postoperative drainage fluid in the prediction of infection of the surgical site after major oncological operations of the head and neck. Br J Oral Maxillofac Surg, 2015; 53:200–203.
17.
PoolC, KassJ, SpivackJ, et al.Increased surgical site infection rates following clindamycin use in head and neck free tissue transfer. Otolaryngol Head Neck Surg, 2016; 154:272–278.
18.
WagnerJL, KenneyRM, VazquezJA, et al.Surgical prophylaxis with gram-negative activity for reduction of surgical site infections after microvascular reconstruction for head and neck cancer. Head Neck, 2016; 38:1449–1454.
19.
DurandML, YarlagaddaBB, RichDL, et al.The time course and microbiology of surgical site infections after head and neck free flap surgery. Laryngoscope, 2015; 125:1084–1089.
20.
KamizonoK, SakurabaM, NagamatsuS, et al.Statistical analysis of surgical site infection after head and neck reconstructive surgery. Ann Surg Oncol, 2014; 21:1700–1705.
21.
LotfiCJ, Cavalcanti RdeC, Costa e SilvaAM, et al.Risk factors for surgical-site infections in head and neck cancer surgery. Otolaryngol Head Neck Surg, 2008; 138:74–80.
22.
SaundersS, ReeseS, LamJ, et al.Extended use of perioperative antibiotics in head and neck microvascular reconstruction. Am J Otolaryngol, 2017. pii: S0196-0709(16)30468-9.
23.
Eder-CzembirekC, CzembirekC, BraunP, et al.Surgical site infection in clean–contaminated wounds after multimodal treatment of advanced oral squamous cell carcinoma. J Craniomaxillofac Surg, 2016; 44:1957–1962.
24.
LeeJI, KwonM, RohJL, et al.Postoperative hypoalbuminemia as a risk factor for surgical site infection after oral cancer surgery. Oral Dis, 2015; 21:178–184.
25.
MückeT, RohlederNH, RauA, et al.The value of perioperative antibiotics in the success of oral free flap reconstructions. Microsurgery, 2015; 35:507–511.
26.
FrederickJW, SweenyL, CarrollWR, et al.Outcomes in head and neck reconstruction by surgical site and donor site. Laryngoscope, 2013; 123:1612–1617.
27.
AveryCM, AmeerallyP, CastlingB, et al.Infection of surgical wounds in the maxillofacial region and free flap donor sites with methicillin-resistant Staphylococcus aureus. Br J Oral Maxillofac Surg, 2006; 44:217–221.
28.
Belusic-GobicM, CarM, JureticM, et al.Risk factors for wound infection after oral cancer surgery. Oral Oncol, 2007; 43:77–81.
29.
TianB, IyerNG, TanHK, et al.Novel technique of creating a seal for the vacuum-assisted closure system application in complex head and neck wounds. Head Neck, 2016; 38:E2523–E2526.
30.
DawsonC, GadiwallaY, MartinT, et al.Factors affecting orocutaneous fistula formation following head and neck reconstructive surgery. Br J Oral Maxillofac Surg, 2017; 55:132–135.
31.
GuideraAK, KellyBN, RigbyP, et al.Early oral intake after reconstruction with a free flap for cancer of the oral cavity. Br J Oral Maxillofac Surg, 2013; 51:224–227.
32.
ClokeDJ, GreenJE, KhanAL, et al.Factors influencing the development of wound infection following free-flap reconstruction for intra-oral cancer. Br J Plast Surg, 2004; 57:556–560.
33.
SakamotoY, YanamotoS, OtaY, et al.Magnitude of myocutaneous flaps and factors associated with loss of volume in oral cancer reconstructive surgery. J Oral Maxillofac Surg, 2016; 74:644–649.
34.
MaCY, JiT, OwA, et al.Surgical site infection in elderly oral cancer patients: Is the evaluation of comorbid conditions helpful in the identification of high-risk ones?. J Oral Maxillofac Surg, 2012; 70:2445–2452.
